MAP2K7 and acute myeloid leukemia: These SPs are involved in major hematopoiesis regulatory pathways, such as the Wnt/β-catenin, JAK/STAT, and RAF/MEK/ERK (MAPK) pathways, and are frequently affected by mutations in AML cases.